Clinical trial for Schizophrenia
Official title REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)
ClinicalTrials.gov ID: NCT07006935
What this study is testing
- What it's testing
- The study wants to see if a structured community program called the Clubhouse Model improves thinking, daily life, and brain activity compared to regular outpatient care.
- Who it's for
- Adults who have schizophrenia, schizo‑affective disorder, or schizophreniform disorder.
- What's involved
- Participants will have six visits: three at the start and three six months later. Each visit includes interviews, questionnaires, thinking and memory tests, and one MRI brain scan. Visits last about 90 minutes to two hours and breaks are allowed.
- Time commitment
- The study lasts about six months, with six visits spread over that time.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50
You may be able to join if
- (1) have a DSM-V diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform confirmed by diagnostic assessment and medical record...
- (2) between the ages of 18-50
- (3) stabilized on psychotropic medication as indicated by no changes to the primary psychiatric medication in the last month
- (4) able to read and speak fluent English at a sixth grade level or higher for purposes of informed consent and cognitive testing
- For Clubhouse members, they must be a first-time, newly enrolled member
You likely can't join if
- (1) had previous membership at a Clubhouse (Magnolia or elsewhere)
- (2) have a current severe substance use disorder
- (3) have persistent suicidal or homicidal behavior
- (4) a co-occurring diagnosis of an intellectual or learning disability or neurodevelopment condition (e.g., Autism; based on chart review)
- (5) had recent psychiatric instability requiring hospitalization in the past month;
- (6) history of a traumatic brain injury (TBI; based on record review)
See the full eligibility criteria
- (1) have a DSM-V diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform confirmed by diagnostic assessment and medical record review
- (2) between the ages of 18-50
- (3) stabilized on psychotropic medication as indicated by no changes to the primary psychiatric medication in the last month
- (4) able to read and speak fluent English at a sixth grade level or higher for purposes of informed consent and cognitive testing
- For Clubhouse members, they must be a first-time, newly enrolled member
- (1) had previous membership at a Clubhouse (Magnolia or elsewhere)
- (2) have a current severe substance use disorder
- (3) have persistent suicidal or homicidal behavior
- (4) a co-occurring diagnosis of an intellectual or learning disability or neurodevelopment condition (e.g., Autism; based on chart review)
- (5) had recent psychiatric instability requiring hospitalization in the past month;
- (6) history of a traumatic brain injury (TBI; based on record review)
- (7) contraindicators for MRI (e.g., pacemaker, claustrophobia)
- Participants in the usual care will be excluded if they are a current Clubhouse member or join a Clubhouse during participation in this research
The study team makes the final eligibility decision.
Where it is enrolling
- Cleveland, Ohio, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Cleveland, Ohio, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.